Financial reports
10-K
2023 FY
Annual report
7 Mar 24
10-Q
2023 Q3
Quarterly report
7 Nov 23
10-Q
2023 Q2
Quarterly report
8 Aug 23
10-Q
2023 Q1
Quarterly report
15 May 23
10-K
2022 FY
Annual report
7 Mar 23
10-Q
2022 Q3
Quarterly report
8 Nov 22
10-Q
2022 Q2
Quarterly report
2 Aug 22
10-Q
2022 Q1
Quarterly report
12 May 22
10-K
2021 FY
Annual report
8 Mar 22
10-Q
2021 Q3
Quarterly report
9 Nov 21
Current reports
8-K
Departure of Directors or Certain Officers
28 Mar 24
8-K
Other Events
25 Mar 24
8-K
Departure of Directors or Certain Officers
6 Mar 24
8-K
Neuronetics Reports Record Fourth Quarter and Record Full Year 2023 Financial and Operating Results
5 Mar 24
8-K
Regulation FD Disclosure
5 Mar 24
8-K
Neuronetics Reports Preliminary Fourth Quarter and Fiscal Year 2023 Financial Results
8 Jan 24
8-K
Neuronetics Reports Third Quarter 2023 Financial and Operating Results
7 Nov 23
8-K
Regulation FD Disclosure
7 Nov 23
8-K
Entry into a Material Definitive Agreement
3 Oct 23
8-K
Neuronetics Reports Record Second Quarter 2023 Financial and Operating Results
8 Aug 23
Registration and prospectus
S-3/A
Shelf registration (amended)
9 Nov 22
S-3
Shelf registration
5 Aug 22
S-8
Registration of securities for employees
5 Aug 22
8-A12B/A
Registration of securities on exchange (amended)
9 Apr 21
424B5
Prospectus supplement for primary offering
1 Feb 21
424B5
Prospectus supplement for primary offering
28 Jan 21
S-8
Registration of securities for employees
19 Jan 21
8-A12B
Registration of securities on exchange
8 Apr 20
S-3
Shelf registration
6 Aug 19
S-8
Registration of securities for employees
26 Jul 18
Proxies
DEFA14A
Additional proxy soliciting materials
11 Apr 24
DEF 14A
Definitive proxy
11 Apr 24
DEFA14A
Additional proxy soliciting materials
13 Apr 23
DEF 14A
Definitive proxy
13 Apr 23
DEFA14A
Additional proxy soliciting materials
14 Apr 22
DEF 14A
Definitive proxy
14 Apr 22
DEFA14A
Additional proxy soliciting materials
14 Apr 21
DEF 14A
Definitive proxy
14 Apr 21
DEFA14A
Additional proxy soliciting materials
12 May 20
DEFA14A
Additional proxy soliciting materials
13 Apr 20
Other
EFFECT
Notice of effectiveness
15 Nov 22
CORRESP
Correspondence with SEC
9 Nov 22
UPLOAD
Letter from SEC
10 Aug 22
EFFECT
Notice of effectiveness
16 Aug 19
CORRESP
Correspondence with SEC
13 Aug 19
UPLOAD
Letter from SEC
12 Aug 19
CT ORDER
Confidential treatment order
9 Jul 18
EFFECT
Notice of effectiveness
28 Jun 18
CORRESP
Correspondence with SEC
25 Jun 18
CORRESP
Correspondence with SEC
25 Jun 18
Ownership
SC 13G
Divisadero Street Capital Management, LP
1 Apr 24
4
WILLIAM ANDREW MACAN
1 Mar 24
4
Stephen Furlong
1 Mar 24
4
Stephen Furlong
29 Feb 24
144
Notice of proposed sale of securities
29 Feb 24
4
Keith J Sullivan
28 Feb 24
144
Notice of proposed sale of securities
28 Feb 24
144
Notice of proposed sale of securities
28 Feb 24
144
Notice of proposed sale of securities
27 Feb 24
4
Keith J Sullivan
26 Feb 24